Critical Reagent Processing (FRA:DV4) Operating Income: €-0.32 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:DV4 Critical Reagent Processing Corp FRA:DV4
37 GF Score
Price €0.05
! 1 Warning Sign
View Full Analysis

What is Critical Reagent Processing Operating Income?

Critical Reagent Processing FRA:DV4 37 Operating Income is €-0.32 Mil as of Mar. 2026. GuruFocus rates FRA:DV4 with a GF Score™ of 37/100. The stock has 1 warning sign investors should review.

Critical Reagent Processing's Operating Income for the three months ended in Mar. 2026 was €-0.07 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.32 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Critical Reagent Processing's Operating Income for the three months ended in Mar. 2026 was €-0.07 Mil. Critical Reagent Processing's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Critical Reagent Processing's Operating Margin % for the quarter that ended in Mar. 2026 was %.

Critical Reagent Processing's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Critical Reagent Processing's annualized ROC % for the quarter that ended in Mar. 2026 was -50.95%. Critical Reagent Processing's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -119.35%.


Critical Reagent Processing  (FRA:DV4) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Critical Reagent Processing's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-0.296 * ( 1 - 0% )/( (0.579 + 0.583)/ 2 )
=-0.296/0.581
=-50.95 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Critical Reagent Processing's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.296/( ( (0.246 + max(-0.018, 0)) + (0.25 + max(-0.028, 0)) )/ 2 )
=-0.296/( ( 0.246 + 0.25 )/ 2 )
=-0.296/0.248
=-119.35 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.0090000000000001) - (0.027 + 0 + 0)
=-0.018

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.008) - (0.036 + 0 + 0)
=-0.028

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Critical Reagent Processing's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.074/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Critical Reagent Processing Operating Income Related Terms


Critical Reagent Processing Operating Income Historical Data

* Premium members only.

The historical data trend for Critical Reagent Processing's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Critical Reagent Processing Operating Income Chart

Critical Reagent Processing Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Operating Income
Get a 7-Day Free Trial Premium Member Only -1.71 -1.77 -0.65 -0.36 -0.35

Critical Reagent Processing Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.08 -0.06 -0.11 -0.07
FRA:DV4
37GF Score
Critical Reagent Processing Corp FRA:DV4
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Critical Reagent Processing Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of €-0.32 Mil mean?
Critical Reagent Processing (FRA:DV4) has a Operating Income of €-0.32 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Critical Reagent Processing and its competitors.
Is Critical Reagent Processing's Operating Income too high?
Critical Reagent Processing's current Operating Income is €-0.32 Mil. Overall, Critical Reagent Processing has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Critical Reagent Processing's Operating Income compare to NEM and AU?
Critical Reagent Processing's Operating Income of €-0.32 Mil can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Metals & Mining company?
A good Operating Income depends on the Metals & Mining industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Critical Reagent Processing and its competitors. Critical Reagent Processing's current Operating Income is €-0.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Critical Reagent Processing stock overvalued right now?
Critical Reagent Processing (FRA:DV4) has a current Operating Income of €-0.32 Mil. The current Operating Income is €-0.32 Mil. Critical Reagent Processing's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Critical Reagent Processing (FRA:DV4), the current Operating Income is €-0.32 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Critical Reagent Processing Business Description

Other Exchanges GRXXF:USACRPC:Canada
Address 1681 Chestnut Street, Suite 400, Vancouver, BC, CAN, V6J 4M6
Critical Reagent Processing Corp is engaged in the acquisition and exploration of mineral properties in Canada. The company explores gold and sodium carbonate. The projects of the company include Laguna Santa Maria Project. The project is comprised of two mining concessions which total 500 hectares. It earns maximum revenue from Argentina.
37GF Score

Get the complete analysis for FRA:DV4

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price